SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION IN PATIENTS WITH PARANEOPLASTIC SYNDROME: A SYSTEMATIC REVIEW

Authors

DOI:

https://doi.org/10.53843/bms.v10i14.999

Keywords:

SIADH, Paraneoplastic Syndrome, Schwartz-Bartter Syndrome

Abstract

The syndrome of inappropriate antidiuretic hormone secretion (SIADH) is characterized by the excessive production or action of antidiuretic hormone (ADH), resulting in persistent hyponatremia and inadequate urinary osmolarity increase. In oncology patients, ectopic secretion of ADH by tumor cells is responsible for the paraneoplastic manifestation of SIADH. Objective: To investigate the epidemiological and clinical profile of patients with paraneoplastic syndrome who developed SIADH. Methods: A qualitative systematic review was conducted covering the period from January 2014 to April 2024, according to the PRISMA protocol, using the databases PubMed, Virtual Health Library (BVS), ScienceDirect, and Cochrane Library. Studies were included that met the following eligibility criteria: presence of at least one combination of search terms in the title; English language; freely available full-text articles; addressing SIADH as a paraneoplastic syndrome and case reports. Abstracts, reviews, animal studies, conference proceedings, theses, and dissertations were excluded. Results: Among the 77 publications identified, only 32 met the inclusion criteria. Regarding sociodemographic profile, case reports from North America (43.75%) were more frequent. Male patients had a higher prevalence of SIADH (53.12%). The average age of the patients was 54.06 (±21.23). In the clinical profile, neuroblastoma was the most prevalent type (28.12%). The average serum sodium levels were 118.03 (±8.25) mEq/L. Urinary osmolality ranged between 266 and 902 mOsm/Kg, with a mean of 506.34 (±160.48) mOsm/Kg. Conclusion: The study highlights the relevance of SIADH as a paraneoplastic syndrome, particularly in men. Neuroblastoma was the most frequently associated condition. Future studies with more robust methodological designs are essential to deepen the understanding of SIADH in patients with paraneoplastic syndrome.

References

[1] Baylis PH. The syndrome of inappropriate antidiuretic hormone secretion. Int J Biochem Cell Biol. 2003;35(11):1495–1499. doi:10.1016/s1357-2725(03)00139-0. DOI: https://doi.org/10.1016/S1357-2725(03)00139-0

[2] Hawkins RC. Age and gender as risk factors for hyponatremia and hypernatremia. Clin Chim Acta. 2003;337(1-2):169–172. doi:10.1016/j.cccn.2003.08.001. DOI: https://doi.org/10.1016/j.cccn.2003.08.001

[3] Verbalis JG, Greenberg A, Burst V, Haymann JP, Johannsson G, Peri A, et al. Diagnosing and treating the syndrome of inappropriate antidiuretic hormone secretion. Am J Med. 2016;129(5):537.e9–537.e23. doi:10.1016/j.amjmed.2015.11.005. DOI: https://doi.org/10.1016/j.amjmed.2015.11.005

[4] Bartter FC, Schwartz WB. The syndrome of inappropriate secretion of antidiuretic hormone. Am J Med. 1967;42(5):790–806. doi:10.1016/0002-9343(67)90096-4. DOI: https://doi.org/10.1016/0002-9343(67)90096-4

[5] Kwon DY, Han GH, Ulak R, Ki KD, Lee JM, Lee SK. Syndrome of inappropriate antidiuretic hormone secretion following irinotecan-cisplatin administration as a treatment for recurrent ovarian clear cell carcinoma. Obstet Gynecol Sci. 2017;60(1):115–117. doi:10.5468/ogs.2017.60.1.115. DOI: https://doi.org/10.5468/ogs.2017.60.1.115

[6] Fernández Miró M, Marin Arguedas S, Ferrer Ruscalleda L. Syndrome of inappropriate antidiuretic hormone secretion associated with a SARS-CoV-2 pneumonia. Med Clin (Barc). 2021;156(4):195–196. doi:10.1016/j.medcli.2020.10.003. DOI: https://doi.org/10.1016/j.medcli.2020.10.003

[7] Pelosof LC, Gerber DE. Paraneoplastic syndromes: an approach to diagnosis and treatment. Mayo Clin Proc. 2010;85(9):838–854. doi:10.4065/mcp.2010.0099. DOI: https://doi.org/10.4065/mcp.2010.0099

[8] Ellison DH, Berl T. Clinical practice. The syndrome of inappropriate antidiuresis. N Engl J Med. 2007;356(20):2064–2072. doi:10.1056/NEJMcp066837. DOI: https://doi.org/10.1056/NEJMcp066837

[9] Runkle I, Villabona C, Navarro A, Pose A, Formiga F, Tejedor A, et al. Treatment of hyponatremia induced by the syndrome of inappropriate antidiuretic hormone secretion: a multidisciplinary Spanish algorithm. Nefrologia. 2014;34(4):439–50. doi:10.3265/Nefrologia.pre2014.Apr.12220.

[10] Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. Int J Surg. 2021;88:105906. DOI: https://doi.org/10.1016/j.ijsu.2021.105906

[11] Lewis JL. Equilíbrio de água e sódio. Available at: <https://www.msdmanuals.com/pt/profissional/dist%C3%BArbios-end%C3%B3crinos-e-metab%C3%B3licos/metabolismo-de-l%C3%ADquidos/equil%C3%ADbrio-de-%C3%A1gua-e-s%C3%B3dio>. Accessed January 8, 2025.

[12] Mir F. Urine sodium: reference range, interpretation, collection and panels. Available at: <https://emedicine.medscape.com/article/2088449-overview?form=fpf>. Accessed January 8, 2025.

[13] Wilczynski C. Urine osmolality: reference range, interpretation, collection and panels. Available at: <https://emedicine.medscape.com/article/2088250-overview?form=fpf>. Accessed January 8, 2025.

[14] Yucel D, Mekheal E, Kania B, Aron P, Kapoor A, Tailor RP, et al. A rare case of paraneoplastic syndrome of inappropriate secretion of antidiuretic hormone in cervical squamous cell carcinoma: a case report and literature review. J Community Hosp Intern Med Perspect. 2022;12(5):119–123. doi:10.55729/2000-9666.1109. DOI: https://doi.org/10.55729/2000-9666.1109

[15] Agarwal KA, Soe MH. Beyond the dual paraneoplastic syndromes of small-cell lung cancer with ADH and ACTH secretion: a case report with literature review and future implications. Case Rep Oncol Med. 2018;2018:4038397. doi:10.1155/2018/4038397. DOI: https://doi.org/10.1155/2018/4038397

[16] Oda Y, Tsubouchi H, Ishii N, Kitamura A, Moriyama E, Mitsutome E, et al. A rare case of concomitant Lambert-Eaton myasthenic syndrome and syndrome of inappropriate antidiuretic hormone secretion in a patient with small cell lung carcinoma. Respir Med Case Rep. 2023;46:101930. doi:10.1016/j.rmcr.2023.101930. DOI: https://doi.org/10.1016/j.rmcr.2023.101930

[17] Kennedy GT, Sande CM, Surrey LF, Azari FS, Deshpande C, Singhal S. Anterior mediastinal neuroblastoma associated with syndrome of inappropriate antidiuretic hormone secretion: a morphologic, immunohistochemical, and genetic case report and review of the literature. Int J Surg Pathol. 2022;30(6):689–696. doi:10.1177/10668969221080061. DOI: https://doi.org/10.1177/10668969221080061

[18] Stoll K, Tomkovich A, Howells J. Small cell carcinoma of the bladder presenting with paraneoplastic syndrome of inappropriate antidiuretic hormone. BMJ Case Rep. 2019;12(12):e232128. doi:10.1136/bcr-2019-232128. DOI: https://doi.org/10.1136/bcr-2019-232128

[19] Nyanti L, Samsudin A, Tiong IK. Syndrome of inappropriate antidiuretic hormone secretion and Leser-Trélat syndrome as uncommon paraneoplastic manifestations of renal malignancy - a geriatric experience: a case report. J Med Case Rep. 2019;13(1):188. doi:10.1186/s13256-019-2122-8. DOI: https://doi.org/10.1186/s13256-019-2122-8

[20] Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case reporting guideline development. J Clin Epidemiol. 2014;67(1):46–51. doi:10.1016/j.jclinepi.2013.08.003. DOI: https://doi.org/10.1016/j.jclinepi.2013.08.003

[21] Murad MH. New evidence pyramid. Evid Based Med. 2016;21(4):125–7. doi:10.1136/ebmed-2016-110401. DOI: https://doi.org/10.1136/ebmed-2016-110401

[22] Goldsmith SR, Funk AD. Current approaches to the treatment of hyponatremia. Curr Opin Nephrol Hypertens. 2015;24(5):469–76. doi:10.1097/MNH.0000000000000158.

[23] Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant. 2014;29(Suppl 2):i1–i39. doi:10.1093/ndt/gfu040. DOI: https://doi.org/10.1093/ndt/gfu040

Published

12.08.2025

How to Cite

1.
SYNDROME OF INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION IN PATIENTS WITH PARANEOPLASTIC SYNDROME: A SYSTEMATIC REVIEW. BMS [Internet]. 2025 Aug. 12 [cited 2025 Oct. 7];10(14). Available from: https://revistas.ifmsabrazil.org/bms/article/view/999